To assess potential correlations between CAD risk and the five polymorphisms in miRNAs known to target the PAI-1 3′-UTR, we measured the genotype frequencies of each polymorphism in the patient and the control cohorts (Table 2). Here, SERPINE1 is linked to coronary artery disorder.